We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Nephrology

Nephrology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Worsening Time in Range as a Predictor of Microvascular Complications in Type 1 Diabetes: Insights from a 5-Year Real-World Study
Diabetes & EndocrinologyTime in rangetype 1 diabetes

Worsening Time in Range as a Predictor of Microvascular Complications in Type 1 Diabetes: Insights from a 5-Year Real-World Study

By MedXY|Sep 27, 2026

A 5-year real-world cohort study reveals that declines in CGM-derived time in range correlate with increased microvascular complications in type 1 diabetes, offering prognostic value beyond HbA1c.

Ilofotase Alfa in Preventing Acute Kidney Injury Post-Cardiac Surgery: Insights from a Phase 2 Randomized Trial
Cardiologycardiac surgeryIlofotase alfa

Ilofotase Alfa in Preventing Acute Kidney Injury Post-Cardiac Surgery: Insights from a Phase 2 Randomized Trial

By MedXY|Sep 24, 2026

A phase 2 randomized trial found that ilofotase alfa did not significantly reduce kidney injury or improve outcomes in high-risk patients undergoing on-pump cardiac surgery, though it was safe and well tolerated.

Epidemiology and Outcomes of CRRT in Critically Ill Cirrhosis Patients: Insights from the HRS-HARMONY and CRRTnet Registries
Critical Carecirrhosiscritical care

Epidemiology and Outcomes of CRRT in Critically Ill Cirrhosis Patients: Insights from the HRS-HARMONY and CRRTnet Registries

By MedXY|Sep 24, 2026

This study analyzes the epidemiology, treatment processes, and outcomes of critically ill cirrhosis patients undergoing continuous renal replacement therapy, highlighting high mortality rates, anticoagulation practices, and implications of

Impact of the 2023 Safety Net Policy on Kidney After Lung Transplantation: Early Changes in Transplant Practices and Outcomes
Nephrologylung transplantationtransplant outcomes

Impact of the 2023 Safety Net Policy on Kidney After Lung Transplantation: Early Changes in Transplant Practices and Outcomes

By MedXY|Sep 22, 2026

Following the 2023 US safety net policy for kidney after lung transplantation, a shift from simultaneous lung-kidney transplants to early kidney transplantation post lung transplant was observed, with improved short-term outcomes and reduce

Efficacy and Safety of Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease with High Cardiovascular Risk: A Comprehensive Review
CardiologyRivaroxabananticoagulation

Efficacy and Safety of Low-Dose Rivaroxaban in Advanced Chronic Kidney Disease with High Cardiovascular Risk: A Comprehensive Review

By MedXY|Sep 21, 2026

Low-dose rivaroxaban failed to reduce cardiovascular events but increased major bleeding in advanced CKD patients at high cardiovascular risk, underscoring the need for cautious anticoagulant use.

Unlocking the Potential of Novel Biomarkers for Acute Kidney Injury in the Critically Ill: A Comprehensive Evidence Mapping
Critical Carecritical carebiomarkers

Unlocking the Potential of Novel Biomarkers for Acute Kidney Injury in the Critically Ill: A Comprehensive Evidence Mapping

By MedXY|Sep 18, 2026

This article reviews over 1100 studies on novel biomarkers for acute kidney injury (AKI) in critically ill patients, highlighting their predictive, diagnostic, and management roles while identifying gaps for future clinical implementation.

KDIGO 2026 on Anemia in CKD: Key Recommendations and Practical Guidance for Clinicians
Internal Medicineiron therapyerythropoiesis-stimulating agents

KDIGO 2026 on Anemia in CKD: Key Recommendations and Practical Guidance for Clinicians

By MedXY|Sep 18, 2026

KDIGO 2026 updates anemia care in CKD: evidence-based thresholds for iron therapy, preference for IV iron on hemodialysis, ESA-first approach over HIF-PHIs, individualized Hb initiation, and an ESA maintenance upper Hb target <11.5 g/dL.

Balancing Accuracy and Practicality: Should RAAS-Modifying Drugs Be Withdrawn in Primary Aldosteronism Diagnosis?
Diabetes & Endocrinologyaldosterone-renin ratiohypertension diagnosis

Balancing Accuracy and Practicality: Should RAAS-Modifying Drugs Be Withdrawn in Primary Aldosteronism Diagnosis?

By MedXY|Sep 15, 2026

This article examines the debate on whether RAAS-modifying antihypertensives should be stopped before testing for primary aldosteronism, weighing diagnostic accuracy against patient safety and feasibility.

Advancing SGLT Inhibitor Use for Heart and Kidney Protection in Type 1 Diabetes: Opportunities and Challenges
Diabetes & Endocrinologykidney diseaseSGLT inhibitors

Advancing SGLT Inhibitor Use for Heart and Kidney Protection in Type 1 Diabetes: Opportunities and Challenges

By MedXY|Sep 15, 2026

This article reviews expert perspectives on the efficacy and safety of SGLT inhibitors for cardiovascular and renal disease in type 1 diabetes, outlines translational insights from type 2 diabetes data, and proposes a roadmap for regulatory

Reevaluating Calcineurin Inhibitor Use in Identical Twin Kidney Transplants: Are We Overmedicating?
Internal Medicinegraft survivalimmunosuppression

Reevaluating Calcineurin Inhibitor Use in Identical Twin Kidney Transplants: Are We Overmedicating?

By MedXY|Sep 4, 2026

Despite identical immunogenetic makeup, half of kidney transplant recipients from identical twins remain on calcineurin inhibitors, with no demonstrable benefit in rejection reduction or graft survival over 25 years, calling for critical re

Finerenone in Hypertensive Non-Diabetic Chronic Kidney Disease: Evidence from the FIND-CKD Subgroup Analysis
CardiologyfinerenoneHypertensive Nephropathy

Finerenone in Hypertensive Non-Diabetic Chronic Kidney Disease: Evidence from the FIND-CKD Subgroup Analysis

By MedXY|Sep 3, 2026

Finerenone significantly slows kidney function decline and reduces cardiovascular risk in hypertensive non-diabetic CKD patients, with manageable safety profiles, supporting its therapeutic role beyond diabetes.

Efficacy and Outcomes of Short-Course Perioperative Antiviral Prophylaxis in Hepatitis C Viremic Donor Kidney Transplantation
Infectious DiseasesDirect-Acting Antiviralsantiviral prophylaxis

Efficacy and Outcomes of Short-Course Perioperative Antiviral Prophylaxis in Hepatitis C Viremic Donor Kidney Transplantation

By MedXY|Aug 20, 2026

A 7-day perioperative sofosbuvir/velpatasvir prophylaxis in HCV-positive donor to HCV-negative recipient kidney transplants demonstrated sustained virologic response in over 92% of cases, with favorable 1-year graft survival and function.

Advancing Perioperative Risk Stratification: Predicting Acute Kidney Injury Following Lung Transplantation
Nephrologylung transplantationprediction models

Advancing Perioperative Risk Stratification: Predicting Acute Kidney Injury Following Lung Transplantation

By MedXY|Aug 20, 2026

Comprehensive pre- and early postoperative models predict acute kidney injury and need for renal replacement after lung transplantation, improving risk stratification and enabling targeted nephroprotection.

Ciliogenic Pancreatopathy: A Novel Link Between Ciliopathies and Exocrine Pancreatic Disease
Gastroenterologyadipopancreatosisciliopathies

Ciliogenic Pancreatopathy: A Novel Link Between Ciliopathies and Exocrine Pancreatic Disease

By MedXY|Aug 19, 2026

Researchers unveil ciliogenic pancreatopathy, a new pancreatic disease connected to ciliary gene mutations, highlighting its clinical significance in patients with syndromic ciliopathies and kidney dysfunction.

Finerenone Efficacy in Cardio-Kidney-Metabolic Syndrome Patients With or Without History of Cancer: Insights from the FINE-HEART Analysis
CardiologyfinerenoneCancer Comorbidity

Finerenone Efficacy in Cardio-Kidney-Metabolic Syndrome Patients With or Without History of Cancer: Insights from the FINE-HEART Analysis

By MedXY|Aug 19, 2026

Finerenone reduces mortality, cardiovascular, and kidney complications in cardio-kidney-metabolic syndrome patients regardless of cancer history, while patients with cancer experience greater disease burden and adverse events.

Elevated Preoperative Serum Renin Predicts Vasopressor Need and Acute Kidney Injury in Liver Transplant Patients
Critical Careliver transplantationvasopressor requirements

Elevated Preoperative Serum Renin Predicts Vasopressor Need and Acute Kidney Injury in Liver Transplant Patients

By MedXY|Aug 18, 2026

Pre-liver transplantation elevated serum renin levels correlate with increased intraoperative vasopressor use and postoperative acute kidney injury, suggesting its potential as a predictive biomarker for perioperative management and renal r

Decoding Fibrosis in Lupus Nephritis: Distinct Macrophage-Fibroblast Interactions Fuel Renal Damage
NephrologyMacrophagessingle-cell RNA sequencing

Decoding Fibrosis in Lupus Nephritis: Distinct Macrophage-Fibroblast Interactions Fuel Renal Damage

By MedXY|Aug 17, 2026

Spatially distinct macrophage subsets interact with heterogeneous myofibroblast populations in lupus nephritis, driving maladaptive fibrosis and chronic kidney injury. Identifying these fibroinflammatory circuits offers promising targets fo

Medicaid Expansion and Reduced 1-Year Mortality in Young Adults Initiating Dialysis: A Comprehensive Review
Clinical UpdatesMở rộng Medicaidkidney failure

Medicaid Expansion and Reduced 1-Year Mortality in Young Adults Initiating Dialysis: A Comprehensive Review

By MedXY|Aug 17, 2026

This review synthesizes evidence showing that Medicaid expansion under the Affordable Care Act significantly reduced 1-year mortality among young adults starting dialysis by improving insurance coverage and access to nephrology care.

Enhancing Kidney Transplant Outcomes: The Combined Role of Normothermic Regional Perfusion and Hypothermic Machine Perfusion in Donation After Circulatory Death Donors
Nephrologyhypothermic machine perfusiondonation after circulatory death

Enhancing Kidney Transplant Outcomes: The Combined Role of Normothermic Regional Perfusion and Hypothermic Machine Perfusion in Donation After Circulatory Death Donors

By MedXY|Aug 17, 2026

Sequential use of normothermic regional perfusion and hypothermic machine perfusion in kidney transplants from DCD donors reduces delayed graft function, highlighting enhanced organ preservation strategies.

Net Ultrafiltration Rate and Mortality in Critically Ill CRRT Patients: The Crucial Role of Fluid Balance
Critical Carefluid balancecontinuous renal replacement therapy

Net Ultrafiltration Rate and Mortality in Critically Ill CRRT Patients: The Crucial Role of Fluid Balance

By MedXY|Aug 17, 2026

A multicenter cohort study shows that in critically ill patients undergoing continuous renal replacement therapy, mortality is more closely associated with fluid balance changes than net ultrafiltration rate, emphasizing patient-specific fl

1 / 9
123…9
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles